openPR Logo
Press release

Psychotic Disorder Treatment Market Is Projected To Surge Past A Valuation Of US$ 24.5 Billion By The End Of 2032

10-13-2022 01:40 PM CET | Health & Medicine

Press release from: Fact.MR

Psychotic Disorder Treatment Market Is Projected To Surge Past

The global psychotic disorder treatment market is currently worth US$ 13.6 billion and is expected to exceed US$ 24.5 billion by the end of 2032.

Stress levels in the general population have risen significantly in recent years, leading to an increase in the prevalence of psychotic disorders such as bipolar disorder, schizophrenia, and others.

Fact.MR predicts that worldwide revenue from psychotic disorder treatment will grow at a 6.1% CAGR between 2022 and 2032.

Read Report Overview: https://www.factmr.com/report/568/psychotic-disorder-treatment-market

Competitive Landscape

Psychotic disorder treatment providers are urging regulatory bodies to approve new drugs and treatment therapies in order to expedite the launch of these novel treatments.

AbbVie, a leading biopharmaceutical company, announced in February 2022 that it had submitted a Supplemental New Drug Application to the US Food and Drug Administration (FDA). The application is based on the results of a new clinical trial for cariprazine (VRAYLAR®) as an adjunctive treatment for major depressive disorder (MDD).
BioXcel Therapeutics, a well-known biopharmaceutical company, announced in April 2022 that the U.S. FDA had approved IGALMITM (dexmedetomidine) Sublingual Film for the treatment of bipolar disorder.

To remain 'ahead' of your competitors, request for a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=568

Segmentation of Psychotic Disorder Treatment Industry Research

Psychotic Disorder Treatment Market by Drug Type :

Atypical Antipsychotics

Phenothiazine Antipsychotics

Thioxanthenes

Miscellaneous Antipsychotics Agents

Psychotic Disorder Treatment Market by Indication :

Schizophrenia

Bipolar Disorder

Delusional Disorder

Drug Induced Psychosis

Organic Psychosis

Psychotic Disorder Treatment Market by Distribution Channel :

Hospital Pharmacies

Retail Pharmacies

Drug Store

e-Commerce

Psychotic Disorder Treatment Market by Region :

North America

Latin America

Europe

APAC

MEA

Ask an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=568

Where Should Psychotic Disorder Treatment Providers Concentrate Their Attention?
"Europe's demand for psychotic disorder treatment is at an all-time high."

The Europe psychotic disorder treatment market is expected to be worth $3.45 billion in 2022, with a significant market share of 25.4% in the global industry landscape.

The rising prevalence of severe psychotic disorders, as well as increased awareness of mental health issues, are driving market growth in this region.

In North America, rising cases of severe mental illnesses and a greater emphasis on mental health are expected to drive demand for psychotic disorder treatment. Currently, the region's market has a sales revenue of US$ 2.89 billion and a market share of 21.3%.

Choose Quick and Secure PayPal Payment Mode to Get Full Access to This Report: https://www.factmr.com/checkout/568

How Fact.MR Assists in Making Strategic Moves?

The data provided in the Psychotic Disorder Treatment Market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period. The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psychotic Disorder Treatment Market Is Projected To Surge Past A Valuation Of US$ 24.5 Billion By The End Of 2032 here

News-ID: 2766769 • Views:

More Releases from Fact.MR

Endodontics and Orthodontics Market to Grow by US$ 9.5 Billion from 2024-2034 With a 5.3% CAGR
04-27-2024 | Health & Medicine
Fact.MR
Endodontics and Orthodontics Market to Grow by US$ 9.5 Billion from 2024-2034 Wi …
The global endodontics and orthodontics market (歯内療法および歯科矯正市場) is anticipated to reach a valuation of US$ 9,455.6 million by 2034, with an estimated worth of US$ 5,664.6 million in 2024 and a projected compound annual growth rate (CAGR) of 5.3% over the next decade. This growth trajectory is fueled by escalating initiatives promoting oral health and a rising emphasis on dental aesthetics worldwide. Moreover, the surge in dental diseases is a
Electric Two-Wheeler Market to Grow at 11.1% CAGR, Reaching US$ 203 Billion by 2034
Electric Two-Wheeler Market to Grow at 11.1% CAGR, Reaching US$ 203 Billion by 2 …
The electric two-wheeler market (電動二輪車市場) is projected to grow at an 11.1% CAGR between 2024 and 2034, reaching a value of US$ 203,078.7 million by 2034, according to Fact.MR, a provider of market research and competitive intelligence. The market is witnessing rapid growth and is expected to continue expanding in the coming years. The market's competitiveness is being enhanced by the emergence of new and innovative startups in the electric
Vitamin E Market to Exceed US$ 3.7 Billion by 2033, with 5.3% CAGR
04-26-2024 | Food & Beverage
Fact.MR
Vitamin E Market to Exceed US$ 3.7 Billion by 2033, with 5.3% CAGR
The global vitamin E market (Vitamin-E-Markt) is predicted to grow at a 5.3% CAGR, from $2.2 billion in 2023 to $3.7 billion by 2033. Tocopherols are in high demand in the food and beverage, cosmetics, and animal feed industries due to their high antioxidant content, efficiency, and availability. During the 2016-2020 historical period, vitamin E product sales expanded at a rate of 4%. As of 2021, the market is anticipated to
Head Lice Treatment Formulations Market Set to Reach $712.2 Million by 2033
Head Lice Treatment Formulations Market Set to Reach $712.2 Million by 2033
The global head lice treatment formulations market is expected to be valued at US$ 424.9 million in 2023, growing at a CAGR of 3.8% to US$ 712.2 million by the end of 2033. Constantly increasing demand for natural hair care products has pushed manufacturers to introduce plant-based formulations into the lice treatment market. The side effects of chemical-based formulations are further driving the demand for plant-based products for head lice treatment.

All 5 Releases


More Releases for Disorder

Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior. Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms
Autism Spectrum Disorder (ASD) Treatment Market Report 2018: Segmentation by Aut …
Global Autism Spectrum Disorder (ASD) Treatment market research report provides company profile for Roche Pharmaceuticals, Autism Treatment Plus, Fraser, Retrophin, Inc., Autism Services Inc., Pfizer Inc., SynapDx, Behavior Analysis, Inc., Autism Therapeutics, Curemark LLC and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
Speech Therapy Service Market Report 2018: Segmentation by Product (Speech Disor …
Global Speech Therapy Service market research report provides company profile for Benchmark Therapies, Talk Speech, Language Therapy, Speech Plus, Smart Speech Therapy, Therapy Solutions, Glenda Browne Speech Pathology and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period. This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of